Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yesim Gökmen-Polar

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Oncotarget|October 8, 2016
Upregulation of HSF1 in estrogen receptor positive breast cancerYesim Gökmen-Polar, Sunil Badve
Advances in Anatomic Pathology|August 12, 2015
Tumor Heterogeneity in Breast CancerSunil Badve, Yesim Gökmen-Polar
Science Translational Medicine|January 17, 2014
Multiplexed protein analysisYesim Gökmen-Polar, Sunil Badve
Oncology (Williston Park, N.Y.)|June 5, 2012
Molecular profiling assays in breast cancer: are we ready for prime time?Yesim Gökmen-Polar, Sunil Badve
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 17, 2022
Protein Profiling of Breast Cancer for Treatment Decision-MakingSunil S Badve, Yesim Gökmen-Polar
Current Cancer Drug Targets|October 20, 2018
HSF1 as a Cancer Biomarker and Therapeutic TargetRichard L Carpenter, Yesim Gökmen-Polar
Seminars in Oncology|June 27, 2006
Protein kinase C-beta as a therapeutic target in breast cancerGeorge W Sledge, Yesim Gökmen-Polar
Pathology|September 2, 2019
Ductal carcinoma in situ of breast: update 2019Sunil S Badve, Yesim Gökmen-Polar
Expert Opinion on Therapeutic Targets|July 3, 2023
Targeting the Tumor-Tumor Microenvironment CrosstalkSunil S Badve, Yesim Gökmen-Polar
Biomarkers in Medicine|October 19, 2011
Biomarkers for breast cancer stem cells: the challenges aheadYesim Gökmen-Polar, Harikrishna Nakshatri, Sunil Badve
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Oncotarget|October 8, 2016
Upregulation of HSF1 in estrogen receptor positive breast cancerYesim Gökmen-Polar, Sunil Badve
Advances in Anatomic Pathology|August 12, 2015
Tumor Heterogeneity in Breast CancerSunil Badve, Yesim Gökmen-Polar
Science Translational Medicine|January 17, 2014
Multiplexed protein analysisYesim Gökmen-Polar, Sunil Badve
Oncology (Williston Park, N.Y.)|June 5, 2012
Molecular profiling assays in breast cancer: are we ready for prime time?Yesim Gökmen-Polar, Sunil Badve
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 17, 2022
Protein Profiling of Breast Cancer for Treatment Decision-MakingSunil S Badve, Yesim Gökmen-Polar
Current Cancer Drug Targets|October 20, 2018
HSF1 as a Cancer Biomarker and Therapeutic TargetRichard L Carpenter, Yesim Gökmen-Polar
Seminars in Oncology|June 27, 2006
Protein kinase C-beta as a therapeutic target in breast cancerGeorge W Sledge, Yesim Gökmen-Polar
Pathology|September 2, 2019
Ductal carcinoma in situ of breast: update 2019Sunil S Badve, Yesim Gökmen-Polar
Expert Opinion on Therapeutic Targets|July 3, 2023
Targeting the Tumor-Tumor Microenvironment CrosstalkSunil S Badve, Yesim Gökmen-Polar
Biomarkers in Medicine|October 19, 2011
Biomarkers for breast cancer stem cells: the challenges aheadYesim Gökmen-Polar, Harikrishna Nakshatri, Sunil Badve
Pageof 6